- ROUNDTABLE: Pharmacy’s future in sync with technology
- Coalition of healthcare industry stakeholders address best practices regarding controlled substances
- CDC publishes guidelines for collaborative practice agreements
- Senate passes Drug Quality and Security Act
- NACDS RxImpact shines spotlight on pharmacists' increasing role in delivery of healthcare services
WASHINGTON — The philanthropic arm of the American Pharmacists Association has announced this year's recipients of an award that recognizes pharmacists who increase medication adherence, reduce drug misadventures and promote the use of national treatment guidelines.
The APhA Foundation named the winners of the 2012 Pinnacle Awards. The award, established in 1998, includes three categories: Individual Award for Career Achievement; Group Practices, Health Systems, Health Care Corporations; and Voluntary Health Agencies, Non-Profit Organizations, Associations, Government Agencies and Public-Private Partnerships. The awards, sponsored by Amgen and Merck, will be presented at the APhA's Washington headquarters on June 25.
Walgreens Immunization Services won the Group Practice-Health System-Corporation award for its delivery of vaccinations through its more than 7,800 stores. Specifically, the APhA Foundation said Walgreens has increased coverage for vaccine-preventable diseases by establishing a nationwide capacity to vaccinate patients; improving the process of vaccine administration; and implementing innovative vaccination programs to expand access and convenience.
The University of Connecticut School of Pharmacy, the Connecticut Pharmacists Association and the state's Medicaid program won the Government Agency-Nonprofit Organization-Association award for their collaboration to promote safe medication use in primary care.
Jeff Jellin, president of the Therapeutic Research Center in Stockton, Calif., won the Individual Award for Career Achievement. Jellin also is the editor-in-chief of the center's newsletters, which are designed to improve the use of medications and drug therapy outcomes.